Challenges in liver cancer and possible treatment approaches
Globally, liver cancer is the most frequent fatal malignancy; in the United States, it ranks fifth.
Patients are often diagnosed with liver cancer in advanced stages, contributing to its poor …
Patients are often diagnosed with liver cancer in advanced stages, contributing to its poor …
[HTML][HTML] Functionalized liposomes for targeted breast cancer drug delivery
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …
treatment strategies, it remains a prominent cause of female mortality worldwide …
Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint
MR Islam, F Islam, MH Nafady, M Akter, S Mitra, R Das… - Molecules, 2022 - mdpi.com
Breast cancer (BrCa) is the most common malignancy in women and the second most
significant cause of death from cancer. BrCa is one of the most challenging malignancies to …
significant cause of death from cancer. BrCa is one of the most challenging malignancies to …
Nanoparticle-mediated targeted drug delivery for breast cancer treatment
Breast cancer (BC) is the most common malignancy in women worldwide, and one of the
deadliest after lung cancer. Currently, standard methods for cancer therapy including BC are …
deadliest after lung cancer. Currently, standard methods for cancer therapy including BC are …
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
A Sheikh, S Md, P Kesharwani - Journal of Controlled Release, 2021 - Elsevier
A bird's eye view is now demanded in the area of cancer research to suppress the suffering
of cancer patient and mediate the lack of treatment related to chemotherapy. Chemotherapy …
of cancer patient and mediate the lack of treatment related to chemotherapy. Chemotherapy …
Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer
Cancer is one of the most fatal diseases for decades. Aggregation‐induced emission
luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents …
luminogens (AIEgens) have been recently used as molecular imaging or therapeutic agents …
Targeted therapy and mechanisms of drug resistance in breast cancer
Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …
type and is the leading cause of cancer-related death. There are two main histological …
Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy
W Xia, Z Tao, B Zhu, W Zhang, C Liu, S Chen… - International journal of …, 2021 - mdpi.com
Cancer is one of the primary causes of worldwide human deaths. Most cancer patients
receive chemotherapy and radiotherapy, but these treatments are usually only partially …
receive chemotherapy and radiotherapy, but these treatments are usually only partially …
Advanced phytochemical-based nanocarrier systems for the treatment of breast cancer
Simple Summary Breast cancer is a concern for the healthcare system. Even with the
advancement of science and technology, the current system for therapeutics and diagnostics …
advancement of science and technology, the current system for therapeutics and diagnostics …
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer
R Chadar, P Kesharwani - International Journal of Pharmaceutics, 2021 - Elsevier
Triple negative breast cancer (TNBC) is a subtype of breast cancer characterized by
absence of estrogen (ER) receptor, progesterone (PR) receptor, and human epidermal …
absence of estrogen (ER) receptor, progesterone (PR) receptor, and human epidermal …